Most not too long ago, it has been recognized that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Compared with most opioid receptors, this receptor functions to be a scavenger and doesn't